Emmanouil Tentzeris and Marvin Joshi’s new work demonstrates how a lens‑enabled backscatter system can deliver modern wireless capability without traditional transmitters.

MapHabit, an ATDC-supported startup, uses visual task mapping to help individuals with cognitive challenges build independence through everyday routines.

Olufisayo “Fisayo” Omojokun, Georgia Tech associate dean in the College of Computing, found new energy in teaching through CREATE‑X, where open‑ended entrepreneurship equips students to confidently navigate uncertainty and solve real‑world problems.

Georgia Tech master’s student Victor Espinosa is building Loto Punto, a fintech startup using self‑service kiosks to help unbanked communities convert cash into digital financial access through the CREATE‑X Startup Launch program.

Research published in Science Advances demonstrated the effectiveness of this technology in protecting high-value engineered cell lines.

Georgia Tech engineers have created electronics-free robotic swarms whose collective intelligence emerges entirely from mechanical design, enabling coordinated behavior for applications in medicine, space, and beyond.

Milestone designation signals strong potential to reshape care for dialysis patients and those with chronic knee pain.

When Mason Chilmonczyk, M.S. ME 2017, Ph.D. ME 2020, arrived at Georgia Tech to pursue graduate degrees in mechanical engineering, his goal was to become a professor. Instead, an unexpected turn in his research led him to entrepreneurship.

CogBias AI is developing decision-intelligence technology that helps organizations identify cognitive bias in research questions and surveys before those biases shape business decisions.

To address this issue, researchers at Georgia Tech have developed a new, flexible, sensor-filled fabric to monitor areas at risk of PIs and alert hospital staff when a patient needs to be turned.

Housley and his team are developing self‑assembling nanohydrogels that deliver cancer drugs only when they reach tumor‑specific conditions, aiming to reduce side effects and make treatment more precise across multiple cancer types.

The project aims to move lymphatic disease out of the medical margins and toward patients who have had few meaningful treatment options.